Electrocardiographic Findings in Patients with Acute Methadone Poisoning
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 4 No. 1(Winter) (2014),
7 March 2014
,
Page 11-16
https://doi.org/10.22037/ijmtfm.v4i1(Winter).5427
Abstract
Background:Methadone as a synthetic opioid is widely used for treatment of opioid dependency. One of the causes of methadone related sudden death is cardiac toxicity. This study was aimed to determine the electrocardiographic changes in acute methadone poisoning.
Methods: This is a cross sectional study on patients older than 12 years old with acute methadone poisoning who were admitted in Loghman poisoning center at 2010-2011. Data analysis was done by means of SPSS version 16 and appropriate statistical tests at the significant level of P<0.05.
Results: In one year period, 51 patients with mean age of 40.59±18.27 (31-51) years, including 39 males, with acute methadone poisoning were included in to the study. Seven patients (13.7%) were acutely poisoned, 29 patients (56.8%) had acute on chronic methadone poisoning and others had not reliable history. The mean time of PR, QRS and QTc were 150.2±34.22, 77.06±13.89 and 421.76±43.04ms, respectively. The prolongation of PR, QRS and QTc were observed in 9.8%, 1.96% and 17.6% of patients, respectively. A significant statistical association was observed between PR prolongation and type of poisoning and QRS prolongation and outcome (P=0.035 and 0.009).
Conclusion: The findings of this study indicate the occurrence of cardiac toxicity in patients with acute methadone poisoning. Further studies are required on acute methadone poisoning in patients with known previous cardiac status.
- Methadone
- Electrocardiogram
- Acute poisoning
How to Cite
References
Dole VP, Nys wander M. A medical treatment for diacetylmorphine (heroin) addiction-A clinical trial with methadone hydrochloride-JAMA.1965;193:464-650.
Shaiova L, Berger A, Blinderman CD. Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care. 2008;6:165–76.
Trescot AM, Helm S, Hansen H. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians Guidelines. Pain Physician. 2008;11(2suppl):S5–62.
Advisory Council on the Misuse of Drugs. Reducing drug-related deaths: a report by the Advisory Council on the Misuse of Drugs. Stationery Office, 2000.
Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone and heroin-related deaths in Florida. Am J Drug Alcohol Abuse. 2008;34:347–53.
Martell BA, Arnsten JH, Krantz MJ. Impact of methadone treatment on cardial repolarization and conduction in opioid users. Am J cardiol. 2005-95:915-918.
Krantz MJ, Martin J, stimmel B. QTC interval screening in methadone treatment. Ann Intern med. 2009;150:387-395.
Wong SC, Roberts JR. Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation. J Med Toxicol. 2007;3(4):190-4.
Decerf JA, Gressens B, Brohet C, Liolios A, Hantson P. Can methadone prolong the QT interval Intensive Care Med. 2004;30(8):1690-1.
Mori K, Judith M, Barry S, Davendra M, Mark CP. Qtc Interval Screening in methadone treatment. Ann Intern Med. 2009;150:387–39.
Fareed A, Vayalapalli S, Byrd-Sellers J, Casarella J, Drexler K, Amar R. Onsite Qtc interval screening for patients in methadone maintenance treatment. J Addict Dis. 2010;29:15–22.
Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL. The effect of oral methadone on the Qtc interval in advanced cancer patients: A prospective pilot study. J Palliat Med. 2010;13:638–9.
Esfahani MA, Vosughi AA, Fatehi MH, Shahsanaee A, Teimuri A. Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment. J Res Med Sci. 2012;17(3):264-8.
Roy AK, McCarthy C, Kiernan G, McGorrian C, Keenan E, Mahon NG, Sweeney B. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Addiction. 2012;107(6):1132-9.
Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations. Drug Alcohol Depend. 2013;129(1-2):88-93.
Swensen G. Opioid drug deaths in Western Australia: 1974-1984. Aust Drug Alcohol Rev. 1988;7:181-185.
Williamson PA, Foreman KJ, White JM, Anderson G. Methadone-related overdose deaths in South Australia, 1984-1994. Med J Aust. 1997;166: 302-305.
Shah N, Lathrop SL, Landen MG. Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998-2002. Addiction. 2005;100(2):176-88.
Substance Abuse and Mental Health Services Administration Drug Abuse Warning Network. Annual Medical Examiner Data, 1995. Office of Applied Studies, DHHS Publication No. (SMA) 97-3126, Rockville, MD, 1997.
Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland. BMJ. 2010;341:4851.
- Abstract Viewed: 345 times
- PDF Downloaded: 628 times